Corteva 10-Q Details $527M Q3 Continuing-Ops Loss and $7.4B Debt After Vylor Spin-Off
CTVA is trading near its 52-week low of $9.14 (1.3% above the low) on elevated volume (2.0× avg).
Summary
Corteva's Q3 10-Q shows a $(527) million loss from continuing operations and operating EBITDA of $(68) million, with total debt up to $7,446 million after the October 1 Vylor spin-off and nine-month operating cash flow of $(3,878) million.
Key Events · Earnings and Guidance · CTVA
-
Q3 Loss and EBITDA Swing Negative
Net sales fell 6% to $2,458 million from $2,618 million, and operating EBITDA swung to $(68) million from $49 million a year earlier on Crop Protection pricing pressure and lower volumes.
-
Debt Jumps to $7.4 Billion
Total debt rose to $7,446 million from $2,580 million at December 31, 2025, with short-term borrowings at $3,988 million versus $894 million, reflecting spin-off capital structure work and working capital funding.
-
Nine-Month Cash Burn of $3.9 Billion
Operating cash flow from continuing operations was $(3,878) million versus $(941) million a year earlier, driven by the $1.5 billion discretionary pension contribution and the $610 million Bayer settlement payment.
-
Vylor Spin-Off Closed October 1
Corteva received a $761 million cash distribution from Vylor and used it to repay the $600 million 364-day facility balance and $161 million of commercial paper; the remaining company is the Crop Protection business.
Analysis · CTVA · Industrial Applications And Services
The headline Q3 loss was already public, but the 10-Q reveals how much the balance sheet has changed: total debt jumped to $7,446 million from $2,580 million at year-end 2025, with short-term borrowings at $3,988 million versus $894 million. Nine-month operating cash flow was an outflow of $(3,878) million, driven by a $1.5 billion discretionary pension contribution and the $610 million Bayer settlement payment. The Vylor spin-off closed October 1, 2026, and Corteva received a $761 million cash distribution that it used to repay the $600 million 364-day facility and $161 million of commercial paper. With the stock near its 52-week low, the market is now pricing a smaller, more leveraged Crop Protection-only company whose Q3 operating EBITDA was $(68) million.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTVA was trading at $9.26 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $9.14 to $14.62. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.